Related Experiment Video
Updated: Jul 2, 2026

Cell Type-specific Gene Expression Profiling in the Mouse Liver
Published on: September 17, 2019
Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest
Jennifer W-M Gho1, Wai-Ki Ip, Kathy Y-Y Chan
1Li Ka-Shing Institute of Health Sciences, Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
Abstract:
Transcription factors represent an important class of genes that play key roles in controlling cellular proliferation, cell cycle modulation, and attractive targets for cancer therapy. Here, we report on the novel finding of common ATF5 down-regulations in hepatocellular carcinoma (HCC), a highly malignant tumor with a dismal clinical course. Array-based mapping in HCC highlighted a high and consistent incidence of transcription factor ATF5 repressions on regional chr.19q13. By quantitative reverse transcription-PCR, profound down-regulations of ATF5 were further suggested in 78% of HCC tumors (60 of 77 cases) compared to their adjacent nontumoral liver (P = 0.0004). Restoration of ATF5 expression in 3 nonexpressing HCC cell lines demonstrated a consistent growth inhibitory effect (P < 0.029) but minimal induction on cellular apoptosis. Subsequent flow cytometric investigations revealed a G(2)-M cell cycle arrest in HCC cells that were ectopically transfected with ATF5 (P < 0.002). The differential expressed genes from the functional effects of ATF5 were examined by array profiling. Over a hundred genes were identified, among which ID1 contains the ATF/CREB target binding sequences within its promoter region. An inverse relationship between ATF5 expressions with ID1 transcriptions was verified in HCC (P = 0.019), and a direct interaction of ATF5 on the promoter of ID1 was further demonstrated from electromobility shift assay. Examination of causal events underlying the silencing of ATF5 in HCC suggested copy number losses, promoter hypermethylation, histone deacetylation, and DNA mutations to be the likely inactivating mechanisms. In conclusion, our finding supports a tumor suppressive role for ATF5 in HCC, and highlighted ID1 as a potential downstream target.
Insights
Down-regulation of the transcription factor ATF5 is common in hepatocellular carcinoma (HCC), inhibiting tumor growth and causing cell cycle arrest. ID1 is identified as a downstream target, suggesting ATF5 acts as a tumor suppressor in HCC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Transcription factors regulate crucial cellular processes like proliferation and cell cycle.
- Hepatocellular carcinoma (HCC) is a malignant tumor with poor prognosis.
- ATF5 (Activating Transcription Factor 5) is a transcription factor implicated in various cellular functions.
Purpose of the Study:
- To investigate the role of ATF5 in hepatocellular carcinoma (HCC).
- To identify downstream targets and regulatory mechanisms of ATF5 in HCC.
- To explore ATF5 as a potential therapeutic target for HCC.
Main Methods:
- Array-based mapping and quantitative reverse transcription-PCR to assess ATF5 expression in HCC tumors and adjacent non-tumoral liver.
- Restoration of ATF5 expression in HCC cell lines to evaluate its effect on proliferation, apoptosis, and cell cycle.
- Array profiling to identify differentially expressed genes and electromobility shift assays to confirm ATF5-ID1 interaction.
- Analysis of potential mechanisms for ATF5 silencing, including copy number loss, promoter hypermethylation, histone deacetylation, and DNA mutations.
Main Results:
- Consistent down-regulation of ATF5 was observed in 78% of HCC tumors compared to non-tumoral liver tissue.
- Restoring ATF5 expression in HCC cell lines significantly inhibited growth and induced G2-M cell cycle arrest.
- ID1 was identified as a downstream target of ATF5, with an inverse expression relationship and direct promoter interaction.
- Mechanisms contributing to ATF5 silencing in HCC include copy number losses, promoter hypermethylation, histone deacetylation, and DNA mutations.
Conclusions:
- ATF5 plays a tumor-suppressive role in hepatocellular carcinoma.
- ID1 is a key downstream target regulated by ATF5 in HCC.
- Understanding ATF5 regulation and function provides insights into HCC pathogenesis and potential therapeutic strategies.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Master Transcription Regulators
General Transcription Factors
Cell Specific Gene Expression
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Transcription Factors